25 XP   0   0   10

Braster S.A.
Buy, Hold or Sell?

Let's analyse Braster together

PenkeI guess you are interested in Braster S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Braster S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Braster S.A.

I send you an email if I find something interesting about Braster S.A..

Quick analysis of Braster (30 sec.)










What can you expect buying and holding a share of Braster? (30 sec.)

How much money do you get?

How much money do you get?
zł0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
zł-0.04
Expected worth in 1 year
zł-0.14
How sure are you?
25.6%

+ What do you gain per year?

Total Gains per Share
zł-0.09
Return On Investment
-16.1%

For what price can you sell your share?

Current Price per Share
zł0.58
Expected price per share
zł0.58 - zł0.58
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Braster (5 min.)




Live pricePrice per Share (EOD)

zł0.58

Intrinsic Value Per Share

zł2.48 - zł3.00

Total Value Per Share

zł2.44 - zł2.96

2. Growth of Braster (5 min.)




Is Braster growing?

Current yearPrevious yearGrowGrow %
How rich?-$325.8k$591.9k-$497.3k-526.2%

How much money is Braster making?

Current yearPrevious yearGrowGrow %
Making money-$224k-$342.8k$118.8k53.0%
Net Profit Margin-6,885.2%-1,635.2%--

How much money comes from the company's main activities?

3. Financial Health of Braster (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#324 / 351

Most Revenue
#306 / 351

Most Profit
#127 / 351

Most Efficient
#334 / 351
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Braster? (5 min.)

Welcome investor! Braster's management wants to use your money to grow the business. In return you get a share of Braster.

What can you expect buying and holding a share of Braster?

First you should know what it really means to hold a share of Braster. And how you can make/lose money.

Speculation

The Price per Share of Braster is zł0.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Braster.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Braster, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is zł-0.04. Based on the TTM, the Book Value Change Per Share is zł-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is zł-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is zł0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Braster.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.01-1.1%-0.01-1.3%-0.01-2.0%-0.02-3.9%-0.02-4.2%
Usd Book Value Change Per Share-0.02-4.2%-0.01-1.0%-0.01-1.4%-0.02-2.9%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.02-4.2%-0.01-1.0%-0.01-1.4%-0.02-2.9%0.000.0%
Usd Price Per Share0.14-0.17-0.22-0.27-1.70-
Price to Earnings Ratio-5.65--5.55--5.58--4.19--31.37-
Price-to-Total Gains Ratio-5.89-95.16--2.33--0.56--84.79-
Price to Book Ratio-13.03-17.38-12.58-7.31-14.24-
Price-to-Total Gains Ratio-5.89-95.16--2.33--0.56--84.79-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.144478
Number of shares6921
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.02
Usd Total Gains Per Share-0.01-0.02
Gains per Quarter (6921 shares)-40.26-116.10
Gains per Year (6921 shares)-161.06-464.40
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-161-1710-464-474
20-322-3320-929-938
30-483-4930-1393-1402
40-644-6540-1858-1866
50-805-8150-2322-2330
60-966-9760-2786-2794
70-1127-11370-3251-3258
80-1288-12980-3715-3722
90-1450-14590-4180-4186
100-1611-16200-4644-4650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.039.00.00.0%0.039.00.00.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%5.015.00.025.0%10.029.00.025.6%10.029.00.025.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.039.00.0%0.00.039.00.0%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%5.015.00.025.0%10.029.00.025.6%10.029.00.025.6%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Braster

About Braster S.A.

Braster S.A. provides in-home breast cancer examination device worldwide. The company offers Braster System, a device that allows every woman to perform breast examination independently at home; and Braster Pro, a certified medical device that supports the process of breast examination in clinical conditions. It also provides automatic interpretation of results of thermographic breast examination through Braster telemedical centers. The company was founded in 2008 and is headquartered in Ozarów Mazowiecki, Poland.

Fundamental data was last updated by Penke on 2023-12-01 05:49:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Braster S.A..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Braster earns for each zł1 of revenue.

  • Above 10% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • A Net Profit Margin of -25,133.3% means that zł-251.33 for each zł1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Braster S.A.:

  • The MRQ is -25,133.3%. The company is making a huge loss. -2
  • The TTM is -6,885.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-25,133.3%TTM-6,885.2%-18,248.2%
TTM-6,885.2%YOY-1,635.2%-5,250.0%
TTM-6,885.2%5Y-5,858.4%-1,026.8%
5Y-5,858.4%10Y-4,045.1%-1,813.3%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-25,133.3%-12.0%-25,121.3%
TTM-6,885.2%-15.9%-6,869.3%
YOY-1,635.2%-14.0%-1,621.2%
5Y-5,858.4%-20.6%-5,837.8%
10Y-4,045.1%-22.6%-4,022.5%
1.1.2. Return on Assets

Shows how efficient Braster is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • -3.3% Return on Assets means that Braster generated zł-0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Braster S.A.:

  • The MRQ is -3.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.3%TTM-3.8%+0.5%
TTM-3.8%YOY-5.5%+1.7%
TTM-3.8%5Y-6.8%+3.0%
5Y-6.8%10Y-7.3%+0.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.3%-3.4%+0.1%
TTM-3.8%-4.2%+0.4%
YOY-5.5%-3.7%-1.8%
5Y-6.8%-4.0%-2.8%
10Y-7.3%-4.5%-2.8%
1.1.3. Return on Equity

Shows how efficient Braster is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • 0.0% Return on Equity means Braster generated zł0.00 for each zł1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Braster S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-88.4%+88.4%
TTM-88.4%YOY-68.6%-19.8%
TTM-88.4%5Y-46.9%-41.5%
5Y-46.9%10Y-29.7%-17.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.7%+3.7%
TTM-88.4%-5.2%-83.2%
YOY-68.6%-4.7%-63.9%
5Y-46.9%-5.5%-41.4%
10Y-29.7%-6.8%-22.9%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Braster S.A..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Braster is operating .

  • Measures how much profit Braster makes for each zł1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Braster to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated zł0.00  for each zł1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Braster S.A.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-15.2%+15.2%
TTM-15.2%YOY-1,392.1%+1,376.9%
TTM-15.2%5Y-4,077.5%+4,062.3%
5Y-4,077.5%10Y-3,110.6%-966.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--30.8%+30.8%
TTM-15.2%-28.9%+13.7%
YOY-1,392.1%-11.4%-1,380.7%
5Y-4,077.5%-16.4%-4,061.1%
10Y-3,110.6%-22.4%-3,088.2%
1.2.2. Operating Ratio

Measures how efficient Braster is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 251.00 means that the operating costs are zł251.00 for each zł1 in net sales.

Let's take a look of the Operating Ratio trends of Braster S.A.:

  • The MRQ is 251.000. The company is inefficient in keeping operating costs low. -1
  • The TTM is 67.878. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ251.000TTM67.878+183.122
TTM67.878YOY8.061+59.817
TTM67.8785Y36.569+31.308
5Y36.56910Y28.456+8.113
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ251.0001.452+249.548
TTM67.8781.455+66.423
YOY8.0611.453+6.608
5Y36.5691.461+35.108
10Y28.4561.389+27.067
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Braster S.A..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Braster is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.27 means the company has zł0.27 in assets for each zł1 in short-term debts.

Let's take a look of the Current Ratio trends of Braster S.A.:

  • The MRQ is 0.265. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.320. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.265TTM0.320-0.055
TTM0.320YOY0.393-0.073
TTM0.3205Y0.577-0.257
5Y0.57710Y2.527-1.950
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2652.855-2.590
TTM0.3202.872-2.552
YOY0.3933.689-3.296
5Y0.5773.605-3.028
10Y2.5273.546-1.019
1.3.2. Quick Ratio

Measures if Braster is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Braster to the Medical Devices industry mean.
  • A Quick Ratio of 0.00 means the company can pay off zł0.00 for each zł1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Braster S.A.:

  • The MRQ is 0.002. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.025. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.002TTM0.025-0.023
TTM0.025YOY0.105-0.080
TTM0.0255Y0.087-0.063
5Y0.08710Y1.730-1.642
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0021.536-1.534
TTM0.0251.591-1.566
YOY0.1052.179-2.074
5Y0.0872.175-2.088
10Y1.7302.213-0.483
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Braster S.A..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Braster assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Braster to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.06 means that Braster assets are financed with 105.7% credit (debt) and the remaining percentage (100% - 105.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Braster S.A.:

  • The MRQ is 1.057. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.984. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.057TTM0.984+0.073
TTM0.984YOY0.912+0.073
TTM0.9845Y0.739+0.245
5Y0.73910Y0.508+0.231
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0570.384+0.673
TTM0.9840.383+0.601
YOY0.9120.334+0.578
5Y0.7390.442+0.297
10Y0.5080.464+0.044
1.4.2. Debt to Equity Ratio

Measures if Braster is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Braster to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has zł0.00 debt for each zł1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Braster S.A.:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM22.209-22.209
TTM22.209YOY11.155+11.054
TTM22.2095Y7.781+14.428
5Y7.78110Y4.204+3.577
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.547-0.547
TTM22.2090.548+21.661
YOY11.1550.478+10.677
5Y7.7810.615+7.166
10Y4.2040.692+3.512
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Braster S.A.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every zł1 in earnings Braster generates.

  • Above 15 is considered overpriced but always compare Braster to the Medical Devices industry mean.
  • A PE ratio of -5.65 means the investor is paying zł-5.65 for every zł1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Braster S.A.:

  • The EOD is -5.651. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.651. Based on the earnings, the company is expensive. -2
  • The TTM is -5.555. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.651MRQ-5.6510.000
MRQ-5.651TTM-5.555-0.096
TTM-5.555YOY-5.581+0.027
TTM-5.5555Y-4.189-1.365
5Y-4.18910Y-31.368+27.179
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-5.651-1.014-4.637
MRQ-5.651-1.402-4.249
TTM-5.555-2.061-3.494
YOY-5.581-2.915-2.666
5Y-4.189-2.072-2.117
10Y-31.368-1.969-29.399
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Braster S.A.:

  • The EOD is 21.627. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 21.627. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 5.621. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD21.627MRQ21.6270.000
MRQ21.627TTM5.621+16.006
TTM5.621YOY-1.919+7.541
TTM5.6215Y-4.784+10.405
5Y-4.78410Y-12.003+7.219
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD21.627-1.613+23.240
MRQ21.627-2.309+23.936
TTM5.621-4.456+10.077
YOY-1.919-5.198+3.279
5Y-4.784-5.797+1.013
10Y-12.003-6.482-5.521
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Braster is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -13.03 means the investor is paying zł-13.03 for each zł1 in book value.

Let's take a look of the Price to Book Ratio trends of Braster S.A.:

  • The EOD is -13.029. Based on the equity, the company is expensive. -2
  • The MRQ is -13.029. Based on the equity, the company is expensive. -2
  • The TTM is 17.383. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.029MRQ-13.0290.000
MRQ-13.029TTM17.383-30.413
TTM17.383YOY12.581+4.802
TTM17.3835Y7.313+10.071
5Y7.31310Y14.239-6.926
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-13.0292.194-15.223
MRQ-13.0292.382-15.411
TTM17.3832.554+14.829
YOY12.5813.475+9.106
5Y7.3133.924+3.389
10Y14.2394.350+9.889
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Braster S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.098-0.023-76%-0.032-68%-0.067-32%-0.001-99%
Book Value Per Share---0.0450.013-445%0.081-155%0.412-111%0.715-106%
Current Ratio--0.2650.320-17%0.393-32%0.577-54%2.527-90%
Debt To Asset Ratio--1.0570.984+7%0.912+16%0.739+43%0.508+108%
Debt To Equity Ratio---22.209-100%11.155-100%7.781-100%4.204-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.026-0.031+19%-0.047+83%-0.090+253%-0.098+281%
Free Cash Flow Per Share--0.0070.025-74%-0.024+461%-0.075+1214%-0.123+1938%
Free Cash Flow To Equity Per Share--0.0070.025-74%0.001+616%-0.037+659%-0.011+257%
Gross Profit Margin--1.0001.012-1%1.093-9%1.093-8%1.082-8%
Intrinsic Value_10Y_max--3.003--------
Intrinsic Value_10Y_min--2.483--------
Intrinsic Value_1Y_max--0.022--------
Intrinsic Value_1Y_min--0.021--------
Intrinsic Value_3Y_max--0.278--------
Intrinsic Value_3Y_min--0.261--------
Intrinsic Value_5Y_max--0.791--------
Intrinsic Value_5Y_min--0.716--------
Market Cap17042314.0000%17042314.00019694156.825-13%26217249.425-35%32276820.468-47%200514276.163-92%
Net Profit Margin---251.333-68.852-73%-16.352-93%-58.584-77%-40.451-84%
Operating Margin----0.1520%-13.9210%-40.7750%-31.1060%
Operating Ratio--251.00067.878+270%8.061+3014%36.569+586%28.456+782%
Pb Ratio-13.0290%-13.02917.383-175%12.581-204%7.313-278%14.239-192%
Pe Ratio-5.6510%-5.651-5.555-2%-5.581-1%-4.189-26%-31.368+455%
Price Per Share0.5800%0.5800.670-13%0.892-35%1.098-47%6.824-92%
Price To Free Cash Flow Ratio21.6270%21.6275.621+285%-1.919+109%-4.784+122%-12.003+155%
Price To Total Gains Ratio-5.8930%-5.89395.162-106%-2.326-61%-0.560-91%-84.793+1339%
Quick Ratio--0.0020.025-91%0.105-98%0.087-97%1.730-100%
Return On Assets---0.033-0.038+16%-0.055+68%-0.068+106%-0.073+121%
Return On Equity----0.8840%-0.6860%-0.4690%-0.2970%
Total Gains Per Share---0.098-0.023-76%-0.032-68%-0.067-32%-0.001-99%
Usd Book Value---325822.80094533.450-445%591923.875-155%3012947.739-111%5229752.386-106%
Usd Book Value Change Per Share---0.025-0.006-76%-0.008-68%-0.017-32%0.000-99%
Usd Book Value Per Share---0.0110.003-445%0.020-155%0.103-111%0.178-106%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.006-0.008+19%-0.012+83%-0.023+253%-0.024+281%
Usd Free Cash Flow--49072.700186575.900-74%-177172.375+461%-546505.161+1214%-902022.895+1938%
Usd Free Cash Flow Per Share--0.0020.006-74%-0.006+461%-0.019+1214%-0.031+1938%
Usd Free Cash Flow To Equity Per Share--0.0020.006-74%0.000+616%-0.009+659%-0.003+257%
Usd Market Cap4245240.4170%4245240.4174905814.465-13%6530716.832-35%8040155.978-47%49948106.192-92%
Usd Price Per Share0.1440%0.1440.167-13%0.222-35%0.274-47%1.700-92%
Usd Profit---187821.400-224065.450+19%-342886.150+83%-662145.165+253%-714966.807+281%
Usd Revenue--747.300123491.325-99%27774.650-97%51214.960-99%33149.462-98%
Usd Total Gains Per Share---0.025-0.006-76%-0.008-68%-0.017-32%0.000-99%
 EOD+0 -0MRQTTM+8 -24YOY+13 -195Y+13 -1910Y+13 -19

3.2. Fundamental Score

Let's check the fundamental score of Braster S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.651
Price to Book Ratio (EOD)Between0-1-13.029
Net Profit Margin (MRQ)Greater than0-251.333
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.002
Current Ratio (MRQ)Greater than10.265
Debt to Asset Ratio (MRQ)Less than11.057
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.033
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Braster S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5046.915
Ma 20Greater thanMa 500.580
Ma 50Greater thanMa 1000.580
Ma 100Greater thanMa 2000.580
OpenGreater thanClose0.580
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-06-302022-09-302022-12-312023-03-312023-06-30
Total Stockholder Equity 1,437-845592586509341,584-2,892-1,308



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in PLN. All numbers in thousands.

Summary
Total Assets22,919
Total Liabilities24,227
Total Stockholder Equity-1,308
 As reported
Total Liabilities 24,227
Total Stockholder Equity+ -1,308
Total Assets = 22,919

Assets

Total Assets22,919
Total Current Assets5,087
Long-term Assets5,087
Total Current Assets
Cash And Cash Equivalents 96
Net Receivables 43
Inventory 4,269
Total Current Assets  (as reported)5,087
Total Current Assets  (calculated)4,408
+/- 679
Long-term Assets
Intangible Assets 1,364
Long-term Assets  (as reported)17,832
Long-term Assets  (calculated)1,364
+/- 16,468

Liabilities & Shareholders' Equity

Total Current Liabilities19,184
Long-term Liabilities5,043
Total Stockholder Equity-1,308
Total Current Liabilities
Short Long Term Debt 13,212
Accounts payable 2,190
Total Current Liabilities  (as reported)19,184
Total Current Liabilities  (calculated)15,402
+/- 3,782
Long-term Liabilities
Long-term Liabilities  (as reported)5,043
Long-term Liabilities  (calculated)0
+/- 5,043
Total Stockholder Equity
Total Stockholder Equity (as reported)-1,308
Total Stockholder Equity (calculated)0
+/- 1,308
Other
Capital Stock2,800
Common Stock Shares Outstanding 29,383
Net Debt 13,116
Net Invested Capital 11,904
Net Working Capital -14,097



Balance Sheet

Currency in PLN. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
0
0
0
6,352
5,696
11,262
13,393
13,623
16,302
49,499
48,684
47,667
46,446
51,721
50,044
64,835
56,653
50,606
78,842
73,607
66,909
63,081
57,842
54,528
49,345
47,180
48,831
48,866
45,938
45,105
44,788
35,877
42,771
33,933
33,081
23,737
23,366
23,551
23,474
24,303
23,436
22,919
22,91923,43624,30323,47423,55123,36623,73733,08133,93342,77135,87744,78845,10545,93848,86648,83147,18049,34554,52857,84263,08166,90973,60778,84250,60656,65364,83550,04451,72146,44647,66748,68449,49916,30213,62313,39311,2625,6966,352000
   > Total Current Assets 
0
0
0
3,685
3,073
8,492
10,278
10,509
12,554
42,771
37,999
31,576
28,167
31,466
25,352
25,931
18,473
9,589
38,291
36,801
30,184
26,717
21,990
19,403
14,902
13,338
15,231
15,372
12,910
12,917
13,448
12,747
12,740
12,660
12,676
5,934
6,199
6,307
6,118
6,210
5,588
5,087
5,0875,5886,2106,1186,3076,1995,93412,67612,66012,74012,74713,44812,91712,91015,37215,23113,33814,90219,40321,99026,71730,18436,80138,2919,58918,47325,93125,35231,46628,16731,57637,99942,77112,55410,50910,2788,4923,0733,685000
       Cash And Cash Equivalents 
0
0
0
2,870
1,928
6,665
8,524
7,978
9,639
39,155
33,066
25,578
23,331
25,636
12,844
17,396
8,237
2,498
31,037
25,108
19,505
14,584
9,916
5,393
1,944
176
2,095
2,274
305
113
683
119
54
41
15
27
261
151
393
65
0
96
96065393151261271541541196831133052,2742,0951761,9445,3939,91614,58419,50525,10831,0372,4988,23717,39612,84425,63623,33125,57833,06639,1559,6397,9788,5246,6651,9282,870000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
162
164
0
0
170
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000001700016416200000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124
71
74
49
68
317
344
365
7,267
455
550
767
558
618
206
43
432066185587675504557,2673653443176849747112400000000000000000000000000
       Other Current Assets 
0
0
0
815
1,145
1,827
1,753
2,531
2,915
3,616
4,933
5,998
4,836
5,712
12,281
7,459
9,585
6,106
6,198
10,885
9,472
10,878
10,692
9,771
8,471
8,523
7,473
7,560
7,335
7,242
7,203
7,201
7,217
7,224
7,267
496
550
797
558
0
0
0
0005587975504967,2677,2247,2177,2017,2037,2427,3357,5607,4738,5238,4719,77110,69210,8789,47210,8856,1986,1069,5857,45912,2815,7124,8365,9984,9333,6162,9152,5311,7531,8271,145815000
   > Long-term Assets 
0
0
0
2,667
2,623
2,770
3,115
3,114
3,748
6,728
10,685
16,091
18,279
20,255
24,692
38,904
38,180
41,017
40,551
36,806
36,725
36,364
35,852
35,125
34,443
33,842
33,600
33,494
33,027
32,188
31,340
23,130
30,031
21,273
20,405
17,803
17,167
17,244
17,356
18,093
17,848
17,832
17,83217,84818,09317,35617,24417,16717,80320,40521,27330,03123,13031,34032,18833,02733,49433,60033,84234,44335,12535,85236,36436,72536,80640,55141,01738,18038,90424,69220,25518,27916,09110,6856,7283,7483,1143,1152,7702,6232,667000
       Property Plant Equipment 
0
0
0
1,399
1,394
1,396
1,528
1,541
2,055
4,955
8,908
14,223
16,238
17,708
21,754
22,393
22,323
22,151
22,048
22,001
21,270
21,424
21,482
20,691
20,462
20,232
20,003
20,142
19,905
19,681
19,457
14,447
19,085
14,012
13,798
11,930
11,739
11,602
11,386
0
0
0
00011,38611,60211,73911,93013,79814,01219,08514,44719,45719,68119,90520,14220,00320,23220,46220,69121,48221,42421,27022,00122,04822,15122,32322,39321,75417,70816,23814,2238,9084,9552,0551,5411,5281,3961,3941,399000
       Intangible Assets 
0
0
0
1,178
1,168
1,312
1,524
1,229
1,238
1,172
1,125
1,275
1,449
1,485
1,897
15,399
14,760
14,131
13,758
13,555
14,201
13,690
13,106
13,171
12,642
12,073
11,561
10,906
10,312
9,720
9,126
5,569
7,876
4,221
3,597
3,155
2,710
2,670
2,281
1,907
1,564
1,364
1,3641,5641,9072,2812,6702,7103,1553,5974,2217,8765,5699,1269,72010,31210,90611,56112,07312,64213,17113,10613,69014,20113,55513,75814,13114,76015,3991,8971,4851,4491,2751,1251,1721,2381,2291,5241,3121,1681,178000
       Accumulated depreciation 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,981
2,391
2,780
2,729
2,700
5,645
8,768
5,315
3,190
3,915
4,182
4,091
5,042
0
0
0
0005,0424,0914,1823,9153,1905,3158,7685,6452,7002,7292,7802,3911,98100000000000000000000000000
> Total Liabilities 
0
0
0
431
441
688
4,095
4,811
8,624
5,301
5,801
5,668
6,291
6,427
8,250
29,995
27,550
27,768
23,085
24,810
23,490
24,814
24,250
25,513
24,749
26,033
30,239
28,079
26,343
27,437
27,181
27,974
27,567
28,755
28,944
21,972
21,200
22,114
22,882
23,653
21,852
24,227
24,22721,85223,65322,88222,11421,20021,97228,94428,75527,56727,97427,18127,43726,34328,07930,23926,03324,74925,51324,25024,81423,49024,81023,08527,76827,55029,9958,2506,4276,2915,6685,8015,3018,6244,8114,095688441431000
   > Total Current Liabilities 
0
0
0
451
440
685
4,093
4,811
8,625
5,321
5,863
5,707
6,286
6,487
8,271
12,753
6,822
11,247
6,937
8,488
7,451
19,263
18,841
20,549
19,860
13,441
18,564
23,402
21,718
22,910
22,732
23,596
23,265
24,504
24,776
17,386
16,934
17,910
18,766
17,984
16,260
19,184
19,18416,26017,98418,76617,91016,93417,38624,77624,50423,26523,59622,73222,91021,71823,40218,56413,44119,86020,54918,84119,2637,4518,4886,93711,2476,82212,7538,2716,4876,2865,7075,8635,3218,6254,8114,093685440451000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
7
0
399
678
1,355
1,369
1,446
1,446
11,855
11,937
11,835
11,512
4,307
9,195
12,673
11,534
11,849
11,849
11,994
11,560
11,993
12,293
11,954
12,574
12,717
11,956
0
0
0
00011,95612,71712,57411,95412,29311,99311,56011,99411,84911,84911,53412,6739,1954,30711,51211,83511,93711,8551,4461,4461,3691,355678399070000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,560
11,993
12,293
11,954
12,574
12,717
11,956
12,481
11,132
13,212
13,21211,13212,48111,95612,71712,57411,95412,29311,99311,56000000000000000000000000000000000
       Accounts payable 
0
0
0
116
105
382
103
224
136
253
741
254
866
804
2,282
2,557
481
851
708
1,685
679
790
610
910
607
1,436
981
1,601
1,250
1,392
1,290
1,182
1,231
1,338
1,213
1,182
1,282
1,755
1,473
2,880
2,447
2,190
2,1902,4472,8801,4731,7551,2821,1821,2131,3381,2311,1821,2901,3921,2501,6019811,4366079106107906791,6857088514812,5572,282804866254741253136224103382105116000
       Other Current Liabilities 
0
0
0
335
296
263
3,955
4,540
4,984
5,012
5,054
5,368
5,295
5,514
5,853
9,620
5,484
8,860
4,669
5,167
5,137
6,408
6,129
7,624
7,564
7,411
7,983
8,782
8,681
9,206
9,233
9,532
9,592
10,246
10,361
3,329
2,045
2,528
4,720
20
89
0
089204,7202,5282,0453,32910,36110,2469,5929,5329,2339,2068,6818,7827,9837,4117,5647,6246,1296,4085,1375,1674,6698,8605,4849,6205,8535,5145,2955,3685,0545,0124,9844,5403,955263296335000
   > Long-term Liabilities 
0
0
0
-20
0
2
1
0
-1
-20
-62
-39
5
-60
-21
17,242
20,728
16,521
16,148
16,322
16,039
5,551
5,409
4,964
4,889
12,592
11,675
4,677
4,625
4,528
4,449
4,378
4,302
4,251
4,168
4,586
4,266
4,204
4,116
5,669
5,592
5,043
5,0435,5925,6694,1164,2044,2664,5864,1684,2514,3024,3784,4494,5284,6254,67711,67512,5924,8894,9645,4095,55116,03916,32216,14816,52120,72817,242-21-605-39-62-20-10120-20000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,377
4,304
4,248
4,166
4,414
4,265
4,189
4,118
0
0
0
0004,1184,1894,2654,4144,1664,2484,3044,3770000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,902
5,517
2,096
0
1,676
1,464
1,560
1,352
0
0
0
0001,3521,5601,4641,67602,0965,5172,9020000000000000000000000000000000
> Total Stockholder Equity
0
0
0
5,921
5,255
10,574
9,298
8,812
7,678
44,198
42,883
41,999
40,155
45,294
41,794
34,840
29,103
22,838
55,757
48,797
43,419
38,267
33,592
29,015
24,596
21,147
18,592
20,787
19,594
17,668
17,607
7,903
15,204
5,178
4,137
1,765
2,166
1,437
592
650
1,584
-1,308
-1,3081,5846505921,4372,1661,7654,1375,17815,2047,90317,60717,66819,59420,78718,59221,14724,59629,01533,59238,26743,41948,79755,75722,83829,10334,84041,79445,29440,15541,99942,88344,1987,6788,8129,29810,5745,2555,921000
   Common Stock
0
0
0
250
250
300
300
300
301
561
561
561
561
617
617
617
617
617
917
917
917
917
917
917
917
917
1,079
1,903
2,226
1,948
2,226
2,226
2,529
2,529
2,529
2,529
2,744
2,529
2,756
0
0
0
0002,7562,5292,7442,5292,5292,5292,5292,2262,2261,9482,2261,9031,079917917917917917917917917617617617617617561561561561301300300300250250000
   Retained Earnings Total Equity000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
107,573
106,958
107,780
0
109,847
109,847
109,847
0
0
0
0
0
0
0
0000000109,847109,847109,8470107,780106,958107,5730000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
11,571
11,571
17,663
17,626
17,816
17,814
54,906
54,756
54,756
54,756
61,929
61,929
61,929
61,929
61,929
100,478
100,478
100,478
100,478
100,478
100,478
100,478
100,478
102,027
106,802
107,573
108,058
109,327
109,598
109,933
109,847
109,847
109,847
111,437
111,700
111,474
0
0
0
000111,474111,700111,437109,847109,847109,847109,933109,598109,327108,058107,573106,802102,027100,478100,478100,478100,478100,478100,478100,478100,47861,92961,92961,92961,92961,92954,75654,75654,75654,90617,81417,81617,62617,66311,57111,571000



Balance Sheet

Currency in PLN. All numbers in thousands.




Cash Flow

Currency in PLN. All numbers in thousands.




Income Statement

Currency in PLN. All numbers in thousands.